First linezolid-resistant clinical isolates of Mycobacterium tuberculosis

被引：85

作者：

Richter, Elvira ^{[1
]}

Ruesch-Gerdes, Sabine ^{[1
]}

Hillemann, Doris ^{[1
]}

机构：

[1] Forsch Zentrum Borstel, Natl Reference Ctr Mycobacteria, D-23845 Borstel, Germany

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2007年 / 51卷 / 04期

关键词：

D O I：

10.1128/AAC.01113-06

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Linezolid resistance was found in 4 (1.9%) of 210 multidrug-resistant Mycobacterium tuberculosis strains. The MICs of linezolid were 4 mu g/ml (one strain) and 8 mu g/ml (three strains). Since no mutations were detected in potential target genes, the mechanism of resistance remains unclear.

引用

页码：1534 / 1536

页数：3

共 12 条

[1] Oxazolidinones: activity, mode of action, and mechanism of resistance [J].

Bozdogan, B ;

Appelbaum, PC .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 23 (02) :113-119

[2] Molecular basis of intrinsic macrolide resistance in the Mycobacterium tuberculosis complex [J].

Buriánková, K ;

Doucet-Populaire, F ;

Dorson, O ;

Gondran, A ;

Ghnassia, JC ;

Weiser, J ;

Pernodet, JL .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (01) :143-150

[3] Pharmacokinetics and tissue penetration of linezolid following multiple oral doses [J].

Gee, T ;

Ellis, R ;

Marshall, G ;

Andrews, J ;

Ashby, J ;

Wise, R .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) :1843-1846

[4] Rapid detection of Mycobacterium tuberculosis Beijing genotype strains by real-time PCR [J].

Hillemann, D ;

Warren, R ;

Kubica, T ;

Rüsch-Gerdes, S ;

Niemann, S .

JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (02) :302-306

[5] The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin [J].

Lin, AH ;

Murray, RW ;

Vidmar, TJ ;

Marotti, KR .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (10) :2127-2131

[6] mmpL7 gene of Mycobacterium tuberculosis is responsible for isoniazid efflux in Mycobacterium smegmatis [J].

Pasca, MR ;

Guglierame, P ;

De Rossi, E ;

Zara, F ;

Riccardi, G .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (11) :4775-4777

[7] Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials [J].

Rüsch-Gerdes, S ;

Pfyffer, GE ;

Casal, M ;

Chadwick, M ;

Siddiqi, S .

JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (03) :688-692

[8] Ribosomal and non-ribosomal resistance to oxazolidinones: species-specific idiosyncrasy of ribosomal alterations [J].

Sander, P ;

Belova, L ;

Kidan, YG ;

Pfister, P ;

Mankin, AS ;

Bottger, EC .

MOLECULAR MICROBIOLOGY, 2002, 46 (05) :1295-1304

[9]

Shinabarger D, 1999, Expert Opin Investig Drugs, V8, P1195, DOI 10.1517/13543784.8.8.1195

[10] Novel mechanism of resistance to oxazolidinones, macrolides, and chloramphenicol in ribosomal protein L4 of the pneumococcus [J].

Wolter, N ;

Smith, AM ;

Farrell, DJ ;

Schaffner, W ;

Moore, M ;

Whitney, CG ;

Jorgensen, JH ;

Klugman, KP .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (08) :3554-3557

← 1 2 →